56 Bionanotechnology for Gene and Drug Delivery II


Description:
Bionanotechnology uses concepts from chemistry, physics, and molecular biology to identify components and processes for the construction of nanomaterials and nanodevices for health care. This session invites papers that focus on the design and development of nanomaterials and nanodevices for gene and drug delivery. Topics of interest include, but are not limited to: novel methods and compositions to design gene and drug delivery systems at the nanoscale level, and the effects of the sizes of gene and drug delivery systems on gene and drug release kinetics, and pharmacokinetics, cellular uptake, biological transport, and bioefficacy of gene- and drug-carrier complexes. Bionanotechnology Graduate students: By applying to this session you may be eligible for the 22b Bionanotechnology Graduate Student Award Session (22B09) established to honor students whose research achievements in bionanotechnology demonstrates a high level of excellence. See session 22B09 for more details.

Sponsor:
Bionanotechnology


Chair:
Joo-Youp Lee
Associate Professor
University of Cincinnati
Chemical Engineering
Cincinnati, OH
45221
Email: joo.lee@uc.edu

Co-chairs:
Elizabeth Nance
Dr.
University of Washington
Chemical Engineering
Seattle, WA
Phone Number: 206-543-2216
Email: eanance@uw.edu

Yoonjee Park
Assistant Professor
University of Cincinnati
Biomedical, Chemical & Environmental Engineering
Cincinnati, OH
Phone Number: 5135561359
Email: parkye@ucmail.uc.edu

Aaron C. Anselmo
Massachusetts Institute of Technology
Koch Institute for Integrative Cancer Research
Cambridge, MA
93106
Email: Aaroncanselmo@gmail.com


Papers:
56a
Carbon Nanotube-Assisted Delivery of Genetic Material into Mature Plants
Gozde Sultan Demirer, UC Berkeley; Markita Landry, University of California Berkeley
56b
On-Demand Delivery and Monitoring of Drug
Yoonjee Park, University of Cincinnati; Zhe Zhang, University of Cincinnati; Madison Taylor, University of Cincinnati
56c
Drug Release from Nanoparticles: Modulating Hydrophobic Prodrug Degradation Rates with Lipid Excipients
Brian K. Wilson, Princeton University; Robert K. Prud'homme, Princeton University
56d
Peptide Modified Liposomes for Treatment of Multiple Myeloma Via Selective Targeting of CD138 and Dual Targeting of CD138 and VLA-4
David Omstead, University of Notre Dame; Matt Lecinski, University of Notre Dame; Tanyel Kiziltepe, University of Notre Dame; Basar Bilgicer, University of Notre Dame
56e
Modulating Pseudomonas aeruginosa Bacterial Communication with Nanoformulated Signaling Agents
Kurt D. Ristroph, Princeton University; Hoang Lu, Princeton University; Elizabeth Pearson, Princeton University; Gregg Duncan, Johns Hopkins University; Laura Ensign, Johns Hopkins University School of Medicine; Jung Soo Suk, Johns Hopkins University School of Medicine; Justin Hanes, Johns Hopkins University School of Medicine; Robert Prud'homme, Princeton University
56f
Nanoparticle Supported Lipid Bilayers for Drug Delivery
Alexander L. Kelly, Auburn University; Robert D. Arnold, Auburn University; Allan E. David, Auburn University
56g
Fusion of Outer Membrane Vesicles: Surface-Display of Different Epitopes on a Single Vesicle
Yehou Gnopo, Cornell University; Aditya Mirsa, Cornell University; Yeo Eun Kim, Cornell University; Matthew P. DeLisa, Cornell University; Susan Daniel, Cornell University; David Putnam, Cornell University
56h
Precision Nanomedicines to Deliver Kinase Inhibitors to the Tumor Microenvironment
Daniel Heller, Memorial Sloan Kettering Cancer Center; Yosi Shamay, Memorial Sloan-Kettering Cancer Center
Abstract Submissions Closed
See more of this Group/Topical: Nanoscale Science and Engineering Forum